1. Pharmacovigilance Presented By : Vanita Tohan Pharmacology (M.Pharm,Ist year) 2. Introduction 2 "Dying from a disease is sometimes unavoidable. But, dying from an…

1. Pharmacovigilance Presented By : Vanita Tohan Pharmacology (M.Pharm,Ist year) 2. Introduction 2 "Dying from a disease is sometimes unavoidable. But, dying from an…

Slide 1FDA Final Rule & Revised NCI Guidelines for Expedited Reporting of Adverse Events S. Percy Ivy, MD Associate Chief, Senior Investigator Investigational Drug Branch,…

Slide 11 Drug and Therapeutics Committee Session 4. Assessing and Managing Medicine Safety Slide 2 Objectives  Describe the significance of—  Adverse drug reactions…

Slide 1Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management Slide 2 Objectives Recognize Adverse Events and serious adverse events…

1.Dr. Prajeesh Nath E N PG Dept. of Rasasastra & Bhaishajya Kalpana Amrita School of Ayurveda2. Content  Etymology and Definition.  Historical Background.  Aims…

1. 1European Clinical TrialSafety Focus (2013)Presented by:Vaska Tone 2. Clinical Trial Safety2 Legislation and Definitions Investigator Responsibilities Sponsor…

1. 20/03/2014 1 NOUVELLES EXIGENCES EN PHARMACOVIGILANCE EN E.C. 4èmes RENCONTRE DE LA RECHERCHE CLINIQUE , DES ARCs & DES TECs, CNIT PARIS LA DÉFENSE 20 MARS 2014…

1. Pharmacovigilance 1July 9, 2014 2. Introduction 2 "Dying from a disease is sometimes unavoidable. But, dying from an adverse drug reaction is unacceptable“ Pharmacovigilance…

Reviewed by Wat Mitthamsiri, MD • Definitions • Effects to human health • Classifications of adverse drug reactions • Chronological classification • Clinical classification…